Immunity (journal)

Immunity (journal)
Title	Immunity (journal)
Discipline	Immunology
Editor	Peter T. Lee
Publisher	Cell Press
Country	United States
History	1994–present
Frequency	Monthly
Openaccess	Hybrid
Impact	16.902
Impact-year	2022
Abbreviation	Immunity
Website	https://www.cell.com/immunity/home
ISSN	1074-7613
EISSN	1097-4180
CODEN	IUNIEH
LCCN	sn94008768
OCLC	30028319

Immunity (journal). It is a premier monthly peer-reviewed scientific journal published by Cell Press, focusing on all aspects of immunological research. The journal publishes high-impact original research, reviews, and commentaries that advance the understanding of the immune system in health and disease. Its scope encompasses fundamental immunology, translational research, and clinical immunology, serving as a key resource for researchers and clinicians worldwide.

Overview

Immunity (journal) serves as a leading forum for disseminating cutting-edge discoveries in the field of immunology. The journal covers a broad spectrum of topics including innate immunity, adaptive immunity, immune tolerance, autoimmunity, immunodeficiency, cancer immunology, and host-pathogen interaction. It is part of the prestigious Cell Press family of journals, which includes other influential titles like Cell, Immunity, and Science. Articles published in the journal often feature mechanistic insights from studies involving mouse models, human studies, and advanced techniques like single-cell RNA sequencing and CRISPR-Cas9 screening. The editorial board, led by an editor-in-chief, maintains rigorous peer-review standards to ensure the publication of seminal work that shapes the direction of immunological science.

History and background

The journal was established in 1994, founded as a sister publication to the highly regarded journal Cell. Its creation was driven by the rapid expansion and increasing specialization within the field of immunology, necessitating a dedicated high-impact venue. Initially published by Cell Press, a division of Elsevier, it quickly gained prominence under the guidance of its founding editors. Over the decades, Immunity (journal) has evolved to reflect the dynamic nature of the discipline, expanding its scope to include emerging areas such as systems immunology, microbiome research, and immunotherapy. The journal's growth parallels major historical milestones in immunology, including the Human Genome Project and the rise of checkpoint inhibitor therapies, consistently providing a platform for groundbreaking research from institutions like the National Institutes of Health, Harvard University, and the Max Planck Society.

Abstracting and indexing

The journal is extensively abstracted and indexed in major scientific databases, ensuring wide dissemination and accessibility of its content. It is covered by services including Science Citation Index Expanded, Scopus, PubMed, MEDLINE, and Embase. These indexing services are critical for researchers performing literature reviews and meta-analyses. The articles are assigned Digital Object Identifiers (DOIs) for permanent citation and are archived in repositories such as PubMed Central and the CLOCKSS digital archive. This comprehensive indexing supports the journal's high impact factor and its inclusion in rankings by organizations like Clarivate Analytics and its Journal Citation Reports.

Impact and reception

Immunity (journal) is consistently ranked among the top journals in the field of immunology by metrics such as impact factor and Eigenfactor score. Its 2022 impact factor of 16.902 reflects its influence and the frequent citation of its articles in subsequent research published in journals like Nature, Science, and The New England Journal of Medicine. The journal is highly regarded within the academic community, with published work often shaping research agendas at major centers like the Memorial Sloan Kettering Cancer Center and the Broad Institute. It has received accolades and its editors are frequently invited to speak at premier conferences such as the annual meeting of the American Association of Immunologists.

Editorial structure

The journal operates under the leadership of an editor-in-chief, supported by a team of professional scientific editors and an esteemed international editorial board. The current editor-in-chief is Peter T. Lee, who oversees the journal's scientific direction and editorial policies. The editorial board comprises leading immunologists from renowned institutions worldwide, including Rockefeller University, Stanford University, and the University of Oxford. This board assists in peer review, identifies emerging trends, and contributes to the journal's commentary sections. The editorial process is managed by the publisher Cell Press, which ensures adherence to ethical publishing standards set by organizations like the Committee on Publication Ethics.

Notable articles and contributions

Throughout its history, Immunity (journal) has published numerous landmark articles that have fundamentally advanced immunological science. Seminal papers have elucidated the mechanisms of T cell activation, the function of Toll-like receptors, and the biology of regulatory T cells. Notable contributions include early work on cytokine signaling pathways and pivotal studies leading to the development of CAR-T cell therapy for cancers like leukemia. Research from laboratories such as those of Shizuo Akira and Ruslan Medzhitov has been featured, exploring the intricacies of innate immune recognition. These publications have not only been highly cited but have also directly influenced clinical trials and therapeutic strategies developed by companies like Genentech and Novartis.

Category:Elsevier academic journals Category:Immunology journals Category:Monthly journals Category:English-language journals Category:Academic journals established in 1994